Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Italy
Clinical trial register · Italy

Clinical Trials in Italy

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 7 Rome 5 Genova 4 Roma 4 Florence 3

Trials in this register

11 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
BioMarin Pharmaceutical
Phase 2/3
160
Genova, Milan
2026-04-20
By invitation
BioMarin Pharmaceutical
Phase 2
18
Milan, Rome
2026-04-20
Recruiting
BioMarin Pharmaceutical
Phase 2
60
Roma, Genova
2025-07-30
By invitation
BioMarin Pharmaceutical
Phase 3
140
Genoa, Rome
2025-06-20
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Florence, Genova, Roma
2024-11-22
Recruiting
BioMarin Pharmaceutical
Phase 2
100
Florence, Roma, Genova
2024-10-21
Active, closed
BioMarin Pharmaceutical
Phase 1/2
18
Milan, Rome
2024-01-03
Recruiting
BioMarin Pharmaceutical
Observational
400
Genoa, Roma, Milan, Rome
2023-11-27
By invitation
BioMarin Pharmaceutical
Observational
172
Milan
2023-01-01
Recruiting
BioMarin Pharmaceutical
Observational
50
Milan
2022-11-22
Recruiting
BioMarin Pharmaceutical
Observational
450
Bologna, Florence, Milan, Naples, Padova, Palermo, Rome
2022-06-06
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-italy

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Italy?

6 of the 11 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 11 studies
PhaseStudiesRecruitingShare
Observational4336.4%
Phase 24236.4%
Phase 1/2109.1%
Phase 2/3119.1%
Phase 3109.1%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
BioMarin Pharmaceutical116

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Hypochondroplasia (3) Noonan Syndrome (1) Idiopathic Short Stature (1) Phenylketonuria (PKU) (1) Duchenne Muscular Dystrophy (1) Achondroplasia (1) Phenylketonuria, Maternal (1) Hemophilia A (1) Duchenne Muscular Dystrophy (DMD) (1)
→

Browse trials by site location

Milan (7) Rome (5) Genova (4) Roma (4) Florence (3) Genoa (2) Bologna (1) Naples (1) Padova (1) Palermo (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.